MS

New Data Illustrate Novel Mechanism of Action of Laquinimod, an Oral Compound for the Treatment of Multiple Sclerosis
Yahoo
Tue, 04/28/09 - 09:32 am
Teva Pharmaceuticals
MS
multiple sclerosis
laquinimod
Novartis Drug Heralds Era of New Multiple Sclerosis Therapies
Bloomberg
Mon, 04/27/09 - 11:46 am
Novartis
MS
multiple sclerosis
Elan First-Quarter Loss Overshadows Tysabri Sales
Bloomberg
Wed, 04/22/09 - 07:08 am
Elan
Tysabri
earnings
MS
Biogen's Tysabri Reports 6th Case
Yahoo/Zacks.com
Mon, 04/20/09 - 10:54 am
Biogen Idec
Tysabri
MS
multiple sclerosis
PML
Biogen Idec Receives Approval for TYSABRI High Titer Production
Yahoo
Thu, 04/16/09 - 08:33 am
Biogen Idec
Tysabri
FDA
MS
multiple sclerosis
Biogen Idec reports 1Q results after the market closes, Wall Street focuses on MS drugs
Yahoo/AP
Thu, 04/16/09 - 07:56 am
Biogen Idec
earnings
MS
multiple sclerosis
Tysabri
FDA Won't Review Acorda's MS Drug
TheStreet.com
Tue, 03/31/09 - 08:05 am
FDA
MS
multiple sclerosis
Acorda Therapeutics
Fampridine-SR
Teva gets expanded FDA approval for MS drug
Yahoo/AP
Tue, 03/3/09 - 09:16 pm
Teva Pharmaceuticals
FDA
multiple sclerosis
MS
Copaxone
Teva Seeks Deals to Deepen Branded Business in ‘Niche’ Diseases
Bloomberg
Tue, 02/24/09 - 08:42 am
Teva Pharmaceuticals
MS
multiple sclerosis
MS Prize of $1.3 Billion Spurs Merck KGaA, Novartis
Bloomberg
Fri, 02/13/09 - 12:01 pm
MS
multiple sclerosis
Merck KGaA
Novartis
Teva Pharmaceutical Industries, Active Biotech drug candidate gets expedited review by FDA
Yahoo/AP
Fri, 02/13/09 - 07:21 am
Teva Pharmaceuticals
FDA
Active Biotech
laquinimod
MS
multiple sclerosis
New study finds that Genzyme's drug Campath may be an effective treatment for multiple sclerosis
Businessweek
Tue, 02/10/09 - 06:08 am
multiple sclerosis
MS
Genzyme
Campath
Biogen Burdened By Tysabri
Forbes
Sat, 02/7/09 - 12:21 pm
Biogen Idec
MS
Tysabri
Blood-Cleansing Treatment Could Make Tysabri Safer
Bloomberg
Tue, 02/3/09 - 06:11 am
Tysabri
Elan
Biogen Idec
MS
Merck’s Multiple Sclerosis Pill Prevents Relapses
Bloomberg
Mon, 01/26/09 - 11:35 am
MS
multiple sclerosis
Merck KGaA
Biogen shares fall on MS drug competitive outlook
Yahoo/AP
Sat, 01/24/09 - 10:30 am
Biogen Idec
MS
multiple sclerosis
Merck
Peptimmune, Novartis Sign $500M Deal for MS Drug
Bioworld
Sat, 01/17/09 - 09:12 am
PeptImmune
Novartis
MS
multiple sclerosis
Novartis gains option to license MS drug
Fierce Biotech
Fri, 01/16/09 - 09:56 am
PeptImmune
Novartis
MS
multiple sclerosis
Questcor Pharmaceuticals to Expand Sales Force; Continued Positive Growth in MS Market Drives Expansion Decision
PharmaLive
Tue, 01/13/09 - 11:12 am
Questcor Pharmaceuticals
expansions
MS
multiple sclerosis
Elan CEO Defends Tysabri Sales, Citing ‘Good Progress’
WSJ Online
Mon, 12/22/08 - 10:26 am
Elan
Biogen Idec
Tysabri
MS
Kelly Martin

Pages